학술논문
Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials
Document Type
Review Article
Source
In ESMO Open April 2022 7(2)
Subject
Language
ISSN
2059-7029